These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [A national campaign for the promotion of the appropriate use of natriuretic peptide assays in heart failure patients]. Di Lenarda A G Ital Cardiol (Rome); 2016 Jan; 17(1):48-50. PubMed ID: 26901258 [No Abstract] [Full Text] [Related]
30. Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation. Baba M; Yoshida K; Ieda M Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185605 [TBL] [Abstract][Full Text] [Related]
31. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure. Gruson D; Ahn SA; Rousseau MF Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303 [TBL] [Abstract][Full Text] [Related]
32. Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study. Parenica J; Kala P; Pavkova MG; Tomandl J; Spinar J; Littnerova S; Jarkovsky J; Mebazaa A; Tomandlova M; Dastych M; Gottwaldova J; Gayat E Int J Cardiol; 2016 May; 211():96-104. PubMed ID: 26991556 [TBL] [Abstract][Full Text] [Related]
33. Hypervolemic and optivolemic natriuretic peptides in acute heart failure. Xue Y; Taub PR; Fard A; Maisel AS Contrib Nephrol; 2011; 171():74-79. PubMed ID: 21625093 [TBL] [Abstract][Full Text] [Related]
34. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers. Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723 [TBL] [Abstract][Full Text] [Related]
35. [Measurement of natriuretic peptides in heart failure: the good laboratory and clinical practice]. Kovács LG; Nyolczas N; Habon T; Sepp R; Piroth Z; Hajas Á; Boncz I; Tomcsányi J; Kappelmayer J; Merkely B Orv Hetil; 2015 Aug; 156(31):1235-45. PubMed ID: 26211747 [TBL] [Abstract][Full Text] [Related]
36. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908 [TBL] [Abstract][Full Text] [Related]
37. Natriuretic peptides as a prognostic marker and therapeutic target in heart failure. Wright GA; Struthers AD Heart; 2006 Feb; 92(2):149-51. PubMed ID: 16216866 [TBL] [Abstract][Full Text] [Related]
38. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors. Suzuki S; Sugiyama S Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934 [TBL] [Abstract][Full Text] [Related]